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In vivo dosimetry is widely used for patient specific dose evaluation and treatment 
verification in external beam radiation therapy (EBRT). There is a growing interest in using an 
electronic portal imaging device (EPID) for in vivo dosimetry, by correlating pixel values of 
measured EPID images to three-dimensional (3D) dose in the patient. In this research, a non-
iterative dose reconstruction method has been employed, which utilizes phantom and EPID 
response functions calculated from pre-acquired Computed Tomography (CT) image and 
simulated EPID image from Monte Carlo (MC) simulation. The accuracy of reconstructed dose, 
however, is limited by that of the simulated EPID image. In this study, a previously proposed 
density scaled model in XVMC code has been improved by physically relevant effective atomic 
number modeling and employing realistic phase space data.  The new model has been tested 
under various field sizes and phantom thickness, including homogeneous and heterogeneous 
media. It has been shown that the calculated EPID images from the new EPID model are 
agreeable to the measured EPID images after field size and phantom thickness factors applied. 
The improved EPID model in MC code has been used in four-dimensional (4D) dose 
reconstruction. Considering the patient respiratory motion, breathing phase of acquired EPID 
  
images are determined by the phase sorting method for various treatment plans. For each phase, 
dose reconstruction has been performed using the sorted EPID images and 4D CT image of 
corresponding phase. The reconstructed 3D doses of each phase have been transformed to a 
reference phase to calculate the accumulated dose. The reconstructed doses have been shown 
good agreements to the forward 4D calculation in gamma analysis and dose-volume histogram 
(DVH) comparison. Based on the results, the new EPID model and the suggested phase sorting 
method accurately reconstruct the dose to the phantom for the cases shown in this study.   
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1. INTRODUCTION 
External radiation therapy is widely being used for the purpose of cancer treatment. To 
minimize dose to healthy organs while maximizing treatment efficiency, intensity modulated 
radiation therapy (IMRT) technique is finding increased used. It utilizes intensity modulated 
irradiation, either by attenuation through Cerrobend block or through multi-leaf collimators 
(MLCs), to define field shape. For the latter method, the accumulated 3-dimensional dose 
distribution can be achieved by step-and-shoot or dynamic MLCs, which combine multiple field 
shapes defined by collimators. However, in the added complexity of IMRT compared to simple 
open field requires more sophisticated treatment planning and dose estimation. Since the dose 
calculation in the for  IMRT treatment planning required complex calculation, using a treatment 
planning system, instead of hand calculation, was suggested [1]. The generated plan was 
evaluated by performing a quality assurance (QA) test, where it was suggested that the 
pretreatment QA method should be optimized to evaluate complex IMRT treatment plan [2]. In 
many cases, however, it was reported that IMRT treatment was not always accurately delivered 
as planned [3]. Therefore, there had been increasing interest for the evaluation of actual received 
dose during treatment [4]–[9]. 
An electronic portal imaging device (EPID) is proposed as a convenient tool for in vivo 
dosimetry that does not require additional setup process, and therefore reduces time and burden 
for in vivo dosimetry in many clinical institutes. Some researchers suggested EPID dosimetry as 
an essential component of IMRT QA [10]. Also, EPID based real-time treatment verification 
method was studied [11]. 
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In this study, a method for the calculation of actual received dose to the patient from 
external beam radiation therapy (EBRT) was proposed. A dose reconstruction method based on 
acquired cine EPID images, which are acquired in continuous time frame during the treatment 
and patient 4D CT images was used for this purpose. For this, the previously developed EPID 
image prediction model was improved in Monte Carlo (MC) simulation. The calculated EPID 
images from the improved model were used to determine patient’s breathing phase of acquired 
EPID images. The use of EPID as an in vivo dosimeter will enable not only real-time treatment 
evaluation, but also adaptation treatment planning. 
 
1.1 In vivo dosimetry 
To deliver dose to a patient accurately as desired, pretreatment verification is necessary. 
In pretreatment verification, the dose in an idealized condition (for example, homogeneous flat 
water phantom at the isocenter) calculated from a treatment planning system (TPS) is compared 
with the measured dose. The difference between measurement and planning is quantified by the 
gamma index [12] to express level of agreement, which usually allows 3% of dose difference 
(DD) or 3 mm distance to agreement (DTA) at a point in many institutions. Later, a more 
accurate geometrical interpolation method, which interpolates values between two points in 3-
dimensional vector space, for gamma index calculation was suggested [13]. The pretreatment 
verification ensures the machine parameters, such as gantry and MLC motion, dose rate, and 
couch motion are within acceptable parameters. However, IMRT pretreatment QA does not 
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predict patient dose error, since it does not contain any patient information in the measurement 
[14]. 
While pretreatment verification does not involve in patient, in vivo dosimetry requires 
dose evaluation to an actual patient. In vivo is Latin for “within the living”, which denotes the 
use of a living organism for a specific purpose, as opposed to ex vivo or in vitro. In external 
radiation therapy, in vivo dosimetry implies the measurement of actual received dose to the 
patient from the radiation during the treatment. However, since measuring the dose in the patient 
body directly is clinically unavailable, the doses in the patient’s body are correlated by known 
relations to the measured values from the dosimeter which is placed outside or near the point of 
interest. The patient specific QA is performed by in vivo dosimetry which is measuring dose in 
the patient’s body with such an indirect method. Some researchers, however, did not regard the 
devices placed at the entrance side of the patient (e.g., monitoring chamber in the linac head) as 
in vivo dosimeters, since they did not provide patient specific information [7]. 
There are several commonly used in vivo dosimeters to measure dose from the external 
radiation. Thermoluminescent dosimeter (TLD) have been widely used to measure accumulated 
dose during a certain time period to workers under radiation environment, or to measure dose to 
a patient from EBRT or brachytherapy [15]. The TLD materials store absorbed radiation energy 
in metastable states and release energy in the form of visible light when heated. The dose to the 
TLD is measured by the amount of light released, which is proportional to the accumulated 
absorbed dose to the TLD; therefore, it is not suitable for time-resolved in vivo dosimetry. Time-
resolved dosimeters include diode, metal-oxide semiconductor field effect transistors (MOSFET) 
and electronic portal imaging device (EPID). They are able to measure energy deposition in real-
time and the measurement can be read during the treatment. However, diode and MOSFET 
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dosimeters need to be recalibrated after receiving a large dose, which limits continuous usage of 
the dosimeter. The EPID is initially developed for acquisition of MV portal image replacing the 
use of film. Since the EPID does not require additional setup process and is able to obtain 2D 
images, it is a good candidate for in vivo dosimetry in EBRT [7], [16]. 
Using the EPID is an ideal solution for in vivo dosimetry that allows to reduce time and 
effort when compare to other available methods, and therefore can be implemented easily [16]. 
To use the EPID as an in vivo dosimeter, however, the relationship between the EPID image and 
the dose to the patient should be determined based on a patient specific method. The dose 
reconstruction method, which correlates the EPID image and the patient dose, is described in the 
following section. 
 
1.2 Dose reconstruction  
As treatment planning becomes increasingly complex, accurate evaluation of the dose to 
the patient becomes more important. Therefore, dose reconstruction methods have been studied 
by many researchers [11], [17]–[24]. There are two approaches to calculate dose to a patient; 
forward calculation and backward reconstruction. In the forward approach, the dose to the 
patient is calculated based on the information of incident beam to the patient [17], [18], [23]. 
Some researchers utilized Dynalog file to determine MLC position and field shape for dose 
calculation [17], [18]. However, it was reported that mismatches between Dynalog file and real 
MLC positions were observed in some studies [17], [24], [25]. Another group suggested to use 
measured EPID images to determine MLC positions [11], [19], [26]. They calculated the patient 
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dose with MLC positions obtained from the EPID image, but did not use pixel values, which 
containing attenuation information from the patient, on the image for the dose calculation. The 
second approach is backward dose reconstruction; the measured EPID images during the 
treatment were utilized for the dose calculation [27]–[30]. In this approach, dose to a point in the 
patient was correlated to a pixel value on the EPID image. Since transmitted radiation through 
the patient contains valuable information, the backward dose reconstruction method can be used 
for in vivo dosimetry [28], [31]–[33]. 
McNutt et al. proposed an iterative convolution/superposition algorithm [27] to 
reconstruct patient dose. Jarry et al. suggested a dose reconstruction method in 4 steps [34]; (1) 
MC dose calculation, (2) portal image processing, (3) MC phase space reconstruction and (4) 
MC dose and portal image reconstruction. Yeo et al. introduced a non-iterative patient-specific 
dose reconstruction method [35] which utilizes EPID images and the patient CT. They suggested 
generating a phantom response function from the incident beam by Monte Carlo calculation. To 
calculate dose from acquired EPID image, the relationship between predicted EPID image and 
the phantom dose was established (Figure 1). 
Figure 1 shows a simplified method of the dose reconstruction model. The phantom dose 
can be calculated by the equation 
𝑃 = 𝑅𝑃 ∙ 𝑅𝐸
−1 ∙ 𝐸          (1) 
where 𝑅𝑃  is a 2-dimensional phantom response function and 𝑅𝐸  is a 2-dimendional EPID 
response function, respectively. 𝑅𝑃 and 𝑅𝐸 are calculated from Monte Carlo simulation. 𝐸 is the 
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measured EPID image and the phantom dose 𝑃 is reconstructed by the equation. The phantom 
response function 𝑅𝑃  and EPID response function 𝑅𝐸  are patient specific functions; if patient 
anatomy is changed, 𝑅𝑃 and 𝑅𝐸  also have to be recalculated accordingly. 
 
 
 
Figure 1. Phantom response functions in dose reconstruction model. (The picture was reproduced 
from Yeo et al., 2009 [35]) 
 
In this study, the non-iterative method suggested by Yeo et al. [35] was employed for 
the dose reconstruction. The accuracy of reconstructed dose from this method is limited by the 
accuracy of patient CT and EPID image prediction model in Monte Carlo simulation. However, 
improving the accuracy and quality of CT image is beyond the scope of this study. Instead, the 
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accuracy of the EPID image prediction model was improved in this study to provide better 
agreement between predicted and measured images by introducing the realistic physical structure 
of EPID in fast Monte Carlo code. 
 
 
1.3 Structure of EPID 
The EPID was initially developed to replace conventional film portal imaging used in 
pretreatment patient alignment. Later, researchers found its usefulness as an in vivo dosimeter. 
Since the EPID is attached to the linac, it does not require additional setup process, unlike other 
in vivo dosimeters. 
Among many types of EPID, amorphous silicon (aSi) is widely being used because of its 
ability to provide high resolution; linear dose and dose rate response; better image quality 
compared with the other types of EPID, such as ion chamber (IC) matrix or CCD camera; and 
higher sensitivity, less dose per image. The aSi EPID is composed of metal plate, phosphor layer, 
photodiode, capacitor, glass plate and electronic circuits. In phosphor layer, visible photons are 
generated by incident high energy X-rays. Then, the generated visible photons produce electron-
hole pairs in the photodiode. Finally, the electron charges are stored in the capacitor. (Figure 2) 
To construct a two-dimensional image, the electronic circuit periodically reads 
accumulated electrons captured in the capacitive storage. The read-out process is performed by a 
line after another, where a line is formed by one dimensional array of capacitors. Therefore, 
capacitive storages are “dumped” periodically by the circuit, enabling to measure high dose rate. 
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The read-out circuit transfer one-dimensional image information to the image processing unit 
and the 2D image is constructed [36]. 
 
 
 
Figure 2. Schematic illustration (not in scale) of interactions in the structure of a pixel in EPID. 
(The picture was reproduced from Antonuk et al., 2002 [37]) 
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Figure 3. Schematic illustration of (a) direct detection method with the phosphor layer and (b) 
indirect detection method [38]. 
 
The response of EPID is known to be linearly proportional to total dose or dose rate. 
Therefore, some researchers suggested to use the EPID as a dosimeter [39]. However, it was 
found that the response of the EPID was not linear to the incident energy of photons. Some 
researchers studied characteristic of EPID without phosphor layer [37]. In this method, the 
incident photon directly interacts with the photodiode. There are two methods for the image 
detection of the aSi EPID, as shown in Figure 3. For direct detection method, the incident x-ray 
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interacts with the photo capacitor directly, by generating electron/hole pair in the photodiode. In 
this method, the response of the EPID is linearly proportional to the ion chamber. For indirect 
method, however, incident x-ray interacts with phosphor layer and visible light is generated. 
Then, the generated photon is detected in the photodiode. While indirect method has many 
advantages [37], such as fast response and low dose per image, its response is dependent on field 
size [40]. Also, it was reported that it has hypersensitivity to lower energy (<1 MeV) photons 
[41]. El-Mohri et al. [42] tested EPID characteristics with and without phosphor layer and 
concluded that indirect (with phosphor layer) method provides better sensitivity, where direct 
method (without phosphor layer) yields the similar linear responses to the ion chamber. Also, the 
response varies by upper phantom thickness and field size [43], which can be attributed to an 
increase in the low energy scattered component, leading to an over response in the EPID. 
Therefore, the EPID response, measured by pixel value in the subsequent image, is not linearly 
proportional to the dose in water phantom. 
The read-out is not an instantaneous process; the image acquisition requires a short time 
period to read throughout two-dimensional photo capacitor array on the EPID. This time delay 
results in banding artifact on the acquired image, as shown in Figure 4. Woodruff et al. 
suggested taking average of 3 images to eliminate the patterning issue [44]. Therefore, useful 
image can be obtained by averaging subsequent images to reduce the patterning effect due to the 
synchronization with the frequency of linac accelerator and the EPID readout timing. The 
banding artifact can be reduced by choosing a lower frame rate that provides averaged images 
over several frames. Current EPID provides a maximum 10 frames per second (aS500) with 
averaged images by internal software [37], thus the banding artifact is not shown in the acquired 
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image. However, the acquired image still has delay or lag under some conditions, especially 
when field shape is changed during image acquisition [45]. 
 
 
Figure 4. An example of banding artifact on EPID image. The image was acquired with flood 
field and the exposure time was 200 μs. The image level was adjusted by brightness +65% and 
contrast +80% to enhance the artifact. (Measured with Pelkin Elmer XRD 0822 Digital X-Ray 
Detector) 
 
Despite these limitations, such as over-sensitivity to lower energy photons and banding 
artifact issue, EPID is still a good candidate for in vivo dosimetry. There have been many efforts 
to use the aSi EPID for absolute dosimetry for pre-treatment verification[46]. However, due to its 
non-linearity response to the ion chamber, the EPID cannot be modeled by simple homogeneous 
water medium and therefore how to predict an accurate EPID image is a key to success in in vivo 
dosimetry using the EPID. 
 
12 
 
1.4 EPID modeling in Monte Carlo codes 
Offering on-line exit dose, electronic portal imaging devices (EPID) have been 
employed for in vivo dosimetry of radiation deliveries [5]–[8]. For treatment verification using 
EPID, various computational models of the dose image of EPID have been developed [47]–[60]. 
Among them, the most utilized models are characterized by the use of kernels that are pre-
determined dose responses of primary and scattered fluences in EPID [47]–[54]. The kernel-
based models have been widely used due to their fast calculation speed and reasonable accuracy. 
The accuracy of the models was improved by employing kernels based on Monte Carlo 
simulations of EPID [55]–[57]. However, it was reported that the dose calculation from Monte 
Carlo simulation is more accurate than using advanced kernel methods in most cases [61]. Where 
it was not tested in the EPID plane, one may expect that a full Monte Carlo simulation for an 
EPID image prediction is more accurate, not requiring empirical or Monte Carlo based pre-
calculated kernels. 
A continuous effort was exerted to achieve the maximum possible accuracy by modeling 
details of actual structures of EPID and their elemental compositions in a Monte Carlo code. The 
model allowed direct radiation transport through the structures without utilizing the kernels. 
Among them, Siebers et al. modeled EPID (aS500 Varian Medical Systems, Inc.) with a virtual 
detector[58] technique utilizing detector grids in the dose calculation region only, instead of 
performing voxelized calculations across the entire radiation transport media in the 
EGS4/DOSXYZ user code [62] which requires a longer calculation time. The model was not 
tested where phantoms were placed above the EPID. The test, however, is necessary for its 
application in exit dose verification (i.e. exit dosimetry) at a distance from the isocenter.  This is 
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because the exit dose calculation under the phantom located at isocenter is difficult than without 
intervening phantoms by involving radiation transport through heterogeneous media and air gaps. 
Such model, therefore, in principle could be vulnerable to changes in phantom and air gap 
thicknesses and the related scattering contributions [63], [64]. 
EGSnrc is known as the most accurate Monte Carlo code for external radiation dose 
calculation [65], [66] but requires longer calculation time, up to 48 times compared with other 
MC codes [67], [68]. Therefore, efforts to speed up calculation time of EGSnrc/DOSXYZnrc by 
modified calculation method [69] or using GPU [70] were heavily studied. While they showed 
improvement, it was not fast enough for clinical use. Meanwhile, a simplified and fast 
calculation model of EPID based on MC transport for exit dosimetry was introduced by Jung et 
al. [71] The model incorporates structural and elemental composition of EPID (aS1000) by 
homogenized (i.e., water) layers in the XVMC code [72]. To account for heterogeneity in the 
actual composition of EPID structures, each homogeneous layer was assigned the physical 
density of the corresponding structure. While the model produced acceptable accuracy in a 
relatively fast computation time, it generated EPID image responses that are highly dependent on 
the variation of attenuation thicknesses in patient, thus requiring thickness-dependent factors that 
account for differences between measured and calculated EPID images and showed limited 
agreement in the region of beam penumbra. 
The XVMC code simulates voxelized volume to reduce calculation time. Also, to 
simplify calculation, it assumes materials in the simulation as water equivalent; the different 
media was determined by the difference in density. While EGSnrc, which is regarded as the gold 
standard in the external beam simulation, calculates all physical interactions with materials by 
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atomic number modeling, XVMC approximates the interaction with media [72], [73]. The 
Compton scattering is calculated by exactly the same mechanism as in EGS, while the dose from 
photoelectric effect is locally deposited in the voxel where the event occurred. This 
approximation yields fast and relatively accurate results in water-equivalent phantom; however, 
it cannot simulate atomic composition, and therefore the accuracy decreases for higher atomic 
number materials. Therefore, the effect from higher atomic number should be corrected. 
In this study, for exit dosimetry applications, a new virtual detector model in the EGSnrc 
code [74] was developed and the EPID model in the XVMC code was improved by considering 
the effective atomic number of each EPID layer and more accurate beam spectra. A two-fold 
evaluation was performed for the two models by investigating the accuracy of the MC codes in 
water and that of the models in the exit dose plane under homogeneous and heterogeneous media. 
The two-fold evaluation was intended to distinguish the sources of error in the exit plane 
between MC codes and EPID models, offering better understanding of the performance of the 
EPID models. The evaluation of MC codes and MC models of EPID in the exit plane is 
necessary for the in vivo application of the MC models [19]. 
 
1.5 Phase sorting method with dose reconstruction 
 For the actual, patient-specific dose calculation, there have been continuing effort to track 
the exact position of the tumor during the treatment [75]–[78]. If the tumor location is different 
between planning and treatment, the proposed dose reconstruction method in section 1.2 is not 
valid. Since current dose reconstruction methods are machine-oriented, main concerns are MLC 
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position, gantry angle and dose rate. However, for a realistic dose reconstruction, patient 
breathing motion should be considered. When CTV is degraded by the organ motion, larger PTV 
or gating or breath holding should be used [75]. Some researchers studied to determine exact 
position of the tumor during the respiratory motion by using marker implanted near the tumor 
location [76], [77]. However, when the breathing pattern is irregular, the breathing phase is not 
predictable and therefore organ at risk (OAR) sparing cannot achieved [78]. 
Other researchers suggested CT reconstruction methods from measured EPID images 
during the treatment to track a patient’s inter-fractional anatomical change [79], [80]. However, 
these methods were limited when there was not sufficient angular information. Also, the 
reconstructed CT using EPID images with MV photons did not provide accurate density 
information as a kV-CT. Another group suggested intra-fractional tumor tracking method by 
combining kV-CBCT and EPID MV image [9] or MV tumor tracking from the acquired EPID 
image [81], but its application is limited to the calculation of tumor dose. 
It is known that dose calculation on 4D CT is the most accurate for reducing errors 
related to patient breathing motion, unless a patient motion management technique is used [82]–
[85]. Other methods to deliver desired dose to a patient accurately are respiratory gating or 
breath holding. However, those technique may allow slight displacement of the tumor from the 
targeted location [86]–[90]. Due to uncertainty of patient breathing pattern, it is still challenging 
to estimate how accurately the dose was delivered as planned. For patient with self-breath 
holding method, the tumor position has few millimeters variation among each holding step [86], 
[91], [92], which can be regarded as a different breathing phase in 4D CT. Also, tumor position 
may be shifted by intra-fractional or inter-fractional change of the patient. Therefore, 
16 
 
determination of the tumor position would solve this problem, where most effective when breath 
holding method is adopted. 
Cai et al. introduced a 3D dose reconstruction method by phase determination using a 
4D CT  motion model [93] of a digital phantom. They assumed that any respiratory motion can 
be described by sum of basis displacement vector field of the respiratory motion. The acquired 
2D projection images were compared with the reference image generated from 3D phantom and 
the phase was determined by iterative calculation method where the displacement vector field 
was minimized. They tested the method using the digital XCAT phantom; however, the method 
was not fully evaluated with a real phantom. 
The aim of this study is to reconstruct dose from IMRT with free breathing motion. The 
acquired EPID images in cine mode during the treatment were phase-determined by comparing 
with predicted EPID images, and the dose to the patient during each breathing phase is 
reconstructed based on 4D CT images and summed over all phases. The suggested method in this 
study may enable clinicians to monitor accumulated dose from every fraction of the treatment. 
Also, it may be used as a reference to determine whether adaptation to the planning is required. 
 
  
 2. MATERIALS AND METHODS 
This study is consisted of two parts. First, the previously developed EPID model [71] 
was modified by effective atomic number modeling to consider realistic Compton interaction in 
the EPID layers. Also, the penumbra profile was improved by adopting new phase space data 
generated by more realistic linac head modeling. As discussed above, the accuracy of the 
reconstructed dose is determined by the accuracy of the predicted EPID image. Jung et al. 
employed a convolution kernel to match the EPID image profiles [71]. However, if there is a 
steep dose gradient, the suggested method will lose the resolution of the image. In this study, the 
improved EPID model in XVMC was demonstrated and compared with the reference EPID 
model based on EGSnrc with virtual detector technique. 
Second, the improved EPID model was used in 4D dose reconstruction with the phase 
sorting method to reconstruct actual received dose to the phantom. The phantom response 
function was generated from the Monte Carlo simulation and dose to the phantom was 
reconstructed from the acquired cine EPID images. The reconstructed result was compared with 
forward calculation for the evaluation of the accuracy of the predicted EPID image and the phase 
sorting method. 
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2.1 EPID model simulation and evaluation 
2.1.1 EPID model in EGSnrc 
A Varian aS1000 EPID was modeled by employing a virtual detector algorithm[58], 
which is a fast voxelized portal image calculation method, in the EGSnrc MC code [74]. The 
new model is similar to the one that was previously developed by Siebers et al., [58] but 
formatted into the EGSnrc code while allowing user inputs for all structural layers of EPID in 
terms of dimension, density, and elemental composition. The realistically modeled structures in 
this study included an air gap, a copper plate, a phosphor screen, back scattering layers, and other 
layers in EPID. The supporting arm was not modeled; backscattering influence was up to 5% in 
aS500 EPID [94] which was modeled in the virtual detector [58], but found to be insignificant 
for an aS1000 EPID model [64] used in this study. The EPID dose image was calculated in the 
phosphor layer which contributes to the EPID response predominantly with a linear response 
between the energy deposition in the phosphor and the pixel values of the EPID image [95], [96]. 
In order to perform calculation, the input photon source terms were prepared by 
generating 6 MV phase space files for various field sizes under the Varian linac head from the 
EGSnrc/BEAMnrc code [97]. The generated phase space files were then used to calculate exit 
fluence under various phantoms (phantom-phase space files) employed in this study. Finally, the 
calculated phantom-phase space files were used to calculate two-dimensional EPID dose images. 
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2.1.2 EPID improvement in XVMC code 
The realistic structures of EPID employed in the EGSnrc could not be reproduced in the 
XVMC code, which defines structures by finite-sized uniform voxels composited of water-
equivalent materials. Therefore, the thickness and elemental composition of each layer of EPID 
were alternatively modeled in the XVMC code. This was partly achieved by density scaling 
described in eq. (2) in the previous study [71]. 
  
i
iiscaled t
t

1
      (2) 
where ρscaled and t are the scaled physical density and thickness of a layer in the model, 
respectively; ρi and ti are the actual physical density and the thickness of an i-th physical layer of 
EPID, respectively. In the model, if the thicknesses of the layers were smaller than the dimension 
of the voxel, multiple layers as indicated by the index “i”, comprised a single-voxel layer. In the 
current study, in addition to the previous scaling method, the elemental compositions of the 
structures were also considered to improve the model. 
A probability of Compton interaction in a medium is proportional to its electron density 
(electrons/cm
3
), which can be expressed by multiplication of the physical density (mass per unit 
volume) and the number of electrons per unit mass [99], [100]. The number of electrons per unit 
mass is proportional to Z/A, where Z and A are the atomic and the mass numbers of the medium, 
respectively. Since the number of electrons per unit mass of low-Z materials (Z/A of water = 
1.40×10
23
/g, bone = 1.4~1.5×10
23
/g, lung = 1.46×10
23
/g and soft tissue = 1.47×10
23
/g) [100] are 
similar, the physical density-only scaling is acceptable for them. However, the number of 
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electrons per unit mass increases for higher-Z materials (Z/A of glass = 2.74×10
23
/g, Copper = 
2.77×10
23
/g). 
To model high-Z materials in the XVMC code, however, the value of Z/A relative to that 
of water should be considered in the scaling process. For each layer of EPID, the effective 
atomic number Zeff was computed and then a normalized Zeff/A value to that of water, noted as 
Z
n
eff(E), was determined by the Auto-Zeff software [101], which is reported as the most accurate 
method for higher energy (>10 keV) [102], considering the physics of Compton scattering in the 
layer for a given photon energy E. The average photon energy at 150 cm was determined from 
the exit fluence calculations performed in the section 2.1.1; it ranged between 1.7 and 1.8 MeV 
for 6 MV photon beams of varying field sizes of 5×5 cm
2
 to 15×15 cm
2
 that passed through 
phantoms of thicknesses of 10 to 30 cm. The calculated Z
n
eff,i(E=1.75 MeV) of each (i-th) layer 
was then multiplied to the density ρi to determine the scaled effective density, ρeff,i in eq. (3). 
 MeVEZ ieffniieff 75.1,,        (3) 
By using ρeff,i , the Compton interactions in each layer was more physically modeled. 
 Applying the scaled effective density in eq. (2), a corrected effective density of a layer 
was derived in the EPID model in eq. (4), 
  
i
iieff t
t
,Zeffscaled,
1
 ,      (4) 
and used throughout this study. The performance of the corrected model was compared with that 
of the density-only scaled model developed previously [71]. 
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In previous studies, it was found that the dose gradient in penumbra areas of simulated 
EPID images are smaller than that from measurements; the dose gradient across a heterogeneous 
interface was also smaller than those from measurements and EGSnrc calculations as well [43], 
[71]. The XVMC code used a virtual source model [103], which is composited by multiple 
sources with Gaussian spatial distribution in order to reduce calculation time. Therefore, it may 
not be physically accurate near field edges, since the virtual source model was optimized to 
water dose calculation near isocenter, without modeling the physical linac head structure. To 
improve the performance in the penumbra, the phase space files generated from the EGSnrc code 
in the section 2.1.1 were employed for the XVMC calculation. Similarly to the case of the 
EGSnrc model, the phantoms and field sizes were simulated to calculate EPID dose images in 
the phosphor layer of the XVMC model. While the calculations with the EGSnrc code involved 
multi-step process by using phase space data generated from previous steps, the calculations with 
the XVMC code involved only a one-step process of full 3D voxelized dose calculation from the 
phase space above phantoms to the EPID model. 
 
2.1.3 Validation of the EPID models 
One source of discrepancy between calculations and measurements could be attributed 
to the exit fluence accuracy in the plane of EPID that is governed by the fundamental physics 
model of the radiation transport through phantom and air gap layers of various thicknesses. In 
addition, they could be affected by potentially imprecise and/or inaccurate simulation due to 
limitations of the modeling of the actual structural and elemental composition of the EPID under 
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study. Therefore, the validation of the EPID models was separated into two steps: (1) validation 
of the codes with measured absolute doses to water in the plane of EPID under homogeneous and 
heterogeneous phantoms and (2) the validation of the EPID models with EPID measurements. 
The result of the second step contains the two sources of errors described above. 
 
2.1.3.1 Dose to water in the plane of EPID: MC code validation 
Doses were measured in an ion chamber array (PTW, Freiburg, Germany) that was 
placed under a 2 cm-thick buildup layer, including the inherent buildup, and above a 5 cm-thick 
backup phantom. The source-to-detector plane distance (SDD) was 150 cm. Photon beams with 
an energy of 6 MV from Varian Clinac iX, a dose of 200 MUs, and field sizes of 5×5, 10×10, 
and 15×15 cm
2
 were irradiated through various phantoms to the array as shown in Figure 5. 
Since the IC array has a 1-cm resolution with the individual IC dimension of 0.5×0.5×0.5 cm
3
, 
the measurement was repeated after shifting the IC array diagonally by a half of the IC 
interspacing and merged the two measurements, doubling the resolution. The IC array was pre-
calibrated to absolute dose at the isocenter and at the depth of 10 cm. 
The phantoms included homogeneous and heterogeneous phantoms that were 
isocentrically placed as shown in Figure 5 (a) and (b), respectively. The former was 
homogeneous plastic water phantoms (CIRS, Inc., Norfolk, VA) of various thicknesses (10, 20, 
and 30 cm). The latter was constituted of a 3 cm-thick bone phantom or a 5 cm-thick lung 
phantom (Gammex, Inc., Middleton, WI) that were placed with their edges aligned to the beam 
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axis while being sandwiched between homogeneous plastic water phantoms. Detailed phantom 
thicknesses for the heterogeneous phantoms are listed in Table 1. 
 
 Lung 
 
Bone 
Total Thickness (cm) 15 25 
 
13 23 
upper water phantom 5.0 10.0 
 
5.0 10.0 
lung/bone phantom 5.0 5.0 
 
3.0 3.0 
lower water phantom 5.0 10.0 
 
5.0 10.0 
 
Table 1. Thickness configurations of the heterogeneous phantoms 
 
Monte Carlo simulations were performed using the same conditions as the above setups. 
The phantoms of plastic water, lung, and bone used in the experiments were CT scanned and 
imported into the EGSnrc and the XVMC codes for the simulations. The dose calculation by the 
EGSnrc code in water was done by using the DOSXYZnrc user code [104]. The IC array with 
buildup and backup phantoms was replaced with a 7 cm-thick water phantom in the simulation 
and doses were calculated at a 2 cm depth. For comparison, the calculation voxel size was kept 
the same as the IC size (0.5×0.5×0.5 cm
3
). The calculated doses by the two codes had been pre-
calibrated to the absolute dose at the isocenter and at the depth of the dose maximum. The 
statistical uncertainty of the calculations was set to be within 0.2% on the value of the dose 
maximum. The calculation results were compared with the measurements. 
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The patient couch was not modeled in the simulation; instead, a measured couch 
attenuation factor was determined and applied to the simulation results. 
 
 
Figure 5. Experimental setups with (a) the homogeneous phantoms and (b) the heterogeneous 
phantoms. The phantoms were placed at the isocenter and the detectors (IC array or EPID) were 
placed at 150 cm. Phantom thicknesses were 10, 20, and 30 cm for the homogeneous phantom. 
The thicknesses of the lung and the bone phantoms were 5 and 3 cm, respectively. They were 
sandwiched by water phantoms of thicknesses of 5 and 10 cm. 
 
2.1.3.2 Dose to the EPID:EPID model validation 
Measurements of EPID dose images were performed for the same experimental 
conditions used in the dose-to-water measurements as shown in Figure 5. Prior to measurements, 
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the EPID was calibrated by dark field (DF) correction and gain correction. First, DF correction 
was performed for background noise cancelation by an EPID image acquired without radiation 
exposure. Since there was no external radiation, the EPID image should have null values at all 
points over the image; any measured value different from zero is considered as electrical noise 
and subtracted from the measured image. Second, gain correction was performed under 
irradiation with a uniform open field covering >70% of the EPID imaging plane. In this step, the 
sensitivity of each pixel was corrected by two-dimensional gain correction matrix under a 20 cm 
phantom to obtain a uniform image response [71]. 
The two-dimensional pixel-to-pixel calibration between the calculated EPID dose 
images and the measured images was performed under a 20 cm-thick phantom and the field size 
of 27.2×20.8 cm
2
, which covers the imaging plane of the EPID. The calibration was then scaled 
to represent each condition of measurement, i.e. the field size of irradiation and phantom 
thickness, to provide a condition-dependent pixel-to-pixel calibration matrix. This is further 
explained in the result section. For the measurements, the integration mode of image acquisition, 
a dose of 200 MUs, and a dose rate of 300 MU/min were used. 
For each of the experimental condition, the EPID image was also calculated on the MC 
models of EPID for comparative evaluations. The calculated images were then converted to 
measured images using the calibration matrix obtained above. In the EPID calculations, the 
patient couch was not modeled, because the couch was not modeled when the calibration matrix 
was generated. Therefore, neglecting the patient couch did not affect the final value of the 
converted images from the calculations. The pixel size of the calculations was 0.25×0.25 cm
2
; 
the raw pixel size of EPID images was rescaled to the same with calculations for comparison. 
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For the XVMC model, the thickness of the phosphor layer was 0.25 cm, while it was actual 
thickness (in submillimeters) in the EGSnrc model. 
 
2.2 Four-dimensional dose reconstruction with the phase sorting method 
A phase sorting method was developed for the determination of the phase of an object at 
which irradiation occurred. The method consists of forward calculation of cine EPID images 
through a moving object and correlation of measured cine EPID images during treatment with 
the calculated images, searching for, and thus determining the phase at the time of irradiation. A 
schematic flowchart of the method is shown in Figure 6. 
 
 
Figure 6. A workflow for 4D dose reconstruction with phase sorting method 
Look-up EPID image 
prediction
Treatment
Cine EPID image 
acquisition
4D dose 
reconstruction
4D dose
forward calculation
(Evaluation)
Phase Determination of 
Cine EPID images
4D CT 
acquisition
Treatment planning
(Phase Coordination)
MC calculation
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2.2.1 Phantom configurations and EPID measurements 
An in-house breathing motion phantom, representing a tumor within a lung, was 
developed. Polystyrene was used as the tumor material, and a cork was used as the lung material. 
The dimension of the polystyrene cylinder was 3 cm×3.5 cm (diameter×height), and the cork 
was 16.0×16.0×8.0 cm
3
 (length×width×height), as shown in Figure 7. Whole phantom was 
placed on a moving platform that was moving back and forth with 2 cm amplitude and 4 
sec/cycle in sinusoidal motion. 
A Ten-phase 4D dynamic CT was taken for the moving phantom. For the cine EPID 
image measurement, a 6 MV photon beam with 300 MU/min using from Varian Clinac iX was 
irradiated on the phantom with three plans; (1) a static field with fixed jaw opening of 5.0×8.5 
cm
2
, (2) a dynamic field with maximum field size 10×10 cm
2
, where MLCs close in parallel with 
the tumor movement (sliding windows), and (3) an IMRT field with MLCs open and then close 
in parallel with the tumor movement. Cine EPID images with 10 fps were acquired during the 
irradiations. 
Also, to evaluate the phase sorting method, an anthropomorphic digital extended cardio-
torso (XCAT) phantom with respiratory motion was used in this study [105], [106]. A tumor 
with 2 cm diameter was positioned in the lung (see Figure 8). The diaphragm motion was 2 cm 
and the breathing phase was 4 sec. A total of 5 phases of digital phantom were generated for the 
experiment. Detailed experimental condition will be described in section 2.2.4. 
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Figure 7. A cross-sectional CT image of the phantom. The phantom was home-made with cork 
and polystyrene. The lung phantom was sandwiched between water equivalent solid phantom 
and the entire phantom was placed on a sinusoidally moving platform. 
 
 
Figure 8. Cross-sectional images of the digital XCAT phantom. Respiratory phase 3 was shown 
with (a) coronal plane and (b) transversal plane view. The tumor was marked in red color in the 
figure. The resolution was (a) 3.125×1.563 mm
2
 and (b) 3.125×3.125 mm
2
, respectively. 
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2.2.2 Monte Carlo simulation: phantom dose 
The phantom geometry was created for each breathing phase from the CT images. Then, 
EPID layers were attached under the phantom to calculate EPID dose images, as shown in Figure 
9. The generated phantom with EPID layers was converted to XVMC input file format by in-
house MATLAB code. Since XVMC calculates all doses to voxel in the volume geometry, 
forward calculation of phantom dose and EPID dose image prediction were done in a single 
calculation for each CT phase. In this study, the phantom geometries for maximum intensity 
projection (MIP; the intensity of a voxel is determined by the maximum value over all phases), 
average intensity projection (AIP; the intensity of a voxel is determined by the average value 
over all phases) and 4D CTs were created. It is known that the dose calculation on 4D CT is the 
most accurate [83], where the planning on AIP is better than MIP [107]. The doses were 
calculated for MIP, AIP and 4D CTs independently and compared with 4D forward and 
reconstructed dose. 
 
 
Figure 9. Cross-sectional view of the phantom geometry generated for the Monte Carlo 
simulation. The EPID layers were added to the CT image. The beam was irradiated from the left 
of the image. 
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2.2.3 Monte Carlo simulation: reference EPID image 
Reference EPID images were calculated for the phase determination of measured EPID 
images with the same jaw openings as in the measurements, using the improved EPID model in 
this study by an enhanced layer modeling method and employing external phase space files 
generated from EGSnrc/BEAMnrc to improve outputs and penumbra shapes. The patient couch 
was not modeled in the Monte Carlo simulation; the error due to absence of the patient couch 
could be ignored since the acquired EPID images were converted into dose images by a 
simulated calibration image, and the effective thickness of the couch is very small relative to the 
phantom thickness in this study. The MLC shapes were not considered in the reference look-up 
EPID image simulations, since the phase had to be determined by the anatomical information of 
the patient, not the field shape. Also, the introduced 2D gamma method for the phase sorting 
calculates gamma index only within in-field regions; therefore absolute gamma values were not 
critical in the phase determination 
 
2.2.4 Phase sorting of acquired cine EPID images 
The measured cine EPID images were compared with pre-calculated look-up EPID 
images. Prior to the phase comparison, look-up EPID images corresponding to the reference 
phases were calculated by the Monte Carlo simulation using the phantom geometries generated 
from the 4D CT images. Also, pixel values on the measured cine EPID images were converted 
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into EPID dose image by normalization with a calibration EPID image simulated under a 20 cm 
thickness homogeneous phantom with the field size of 10x10 cm
2
, as described in section 2.1.3.2. 
 The 2D gamma method [12] was used for the phase sorting. The gamma values were 
calculated by the equation 
 Γ = √
|rr−rm|2
Δr2
+
|Dr(rr)−Dm(rm)|2
ΔD2
    (5) 
where rr and rm refer to the evaluated distribution points on the look-up image at a reference 
phase and the measured image, respectively. Dr(rr) and Dm(rm) are corresponding value on the 
points. In the original gamma value calculation, Dr(rr) and Dm(rm) represent dose values on 
two-dimensional plane. In this study, the normalized pixel values on the EPID image were 
assumed as dose values for the purpose of comparison of EPID images. Δr and ΔD are distance 
to agreement (DTA) and dose difference (DD) criteria, respectively. In this study, 3 mm/3 % 
criteria was used for the gamma calculation. 
Figure 10 shows schematic workflow of phase determination. To determine phase of a 
measured EPID image, gamma values were calculated by comparing with each phase of look-up 
EPID images. To avoid unnecessary calculation and error, only in-field region was considered in 
the gamma index calculation. Then, the phase of the EPID image was assigned to the reference 
phase where the sum of gamma values is lowest. 
For dynamic or IMRT fields, the tumor could be temporarily shadowed by MLCs during 
the irradiation, which may cause inaccurate phase sorting results. In that case, the phases of 
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EPID images were correlated by interpolation or extrapolation in time frame, based on the sorted 
phases while it was available. 
 
 
Figure 10. Schematic diagram of the phase sorting method. A measured EPID image was 
compared with look-up EPID images at the reference phases to determine phase of the image. 
The phase of measured EPID image was determined where the gamma value was lowest. In this 
example, the gamma value was lowest when compared with reference phase 2 and therefore the 
phase of measured EPID image was sorted. 
 
Since the above phase sorting method utilized the rigid phantom, the method was also 
tested using deformable digital XCAT phantom with respiratory motion to evaluate the phase 
sorting method in a realistic case. The breathing motion was separated into five phases from 
maximum inhale to maximum exhale. Phantom images for each phase were generated and the 
phase 3 was chosen arbitrary as the reference phase. The EPID look-up images were simulated 
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for each phase from MC simulation with the improved EPID model in XVMC code. Since the 
phantom was in digital format, EPID image measurement was replaced by an MV digitally 
reconstructed radiographic (DRR) image calculated from XCAT model using projection image 
generation software included in the XCAT package. Field size of 15×7.5 cm
2
 was used for MV 
image generation and look-up EPID image predictions. The generated MV image was compared 
with look-up EPID images and the phase was determined. 
 
2.2.5 Dose reconstruction and evaluation 
The dose was reconstructed from the phase-sorted acquired EPID images and 
corresponding 4D CT images by following steps. First, phantom response functions and EPID 
response functions for each reference phase were generated. Next, EPID-phantom relations were 
correlated using Eq. (1). Finally, phantom dose for a given phase was reconstructed inversely 
using the EPID-phantom relations. Detailed method was described in section 1.2. The 
reconstructed doses of each phase were transformed into the reference phase (reference exhale 
phase in this study) and summed over the volume. For the comparison, forwardly calculated 4D 
doses from the previous step were also transformed into the maximum exhale phase and summed 
over the volume for further evaluation. 
The PTVs were determined on the acquired MIP, AIP and 4D CT images. Dose to PTV 
and lung were calculated forwardly on MIP, AIP and each phase of 4D CTs. Reconstructed 
DVHs for the PTV and lung were compared with forward calculation, MIP and AIP, respectively. 
Also, doses at the isoplane were compared by 2D gamma method. 
3. RESULTS AND DISCUSSION 
3.1 Evaluation of EPID model in XVMC 
The EPID modeling in MC codes were tested and compared with measurement. In this 
study, the EPID models in two MC codes (EGSnrc and XVMC) were tested. Since EGSnrc is 
known as the most accurate MC code for EBRT, the improved EPID model in XVMC code was 
also evaluated by comparing with the EGSnrc based model. 
 
3.1.1 Dose to water in the plane of EPID: Monte Carlo code validation 
For the MC code validation, doses were compared with the ion chamber measurement 
with SAD setup. The depths of measured points were 10, 20 and 30 cm and the field size was 
10×10 cm2. The solid water phantom was placed at the isocenter with more than 10 cm-thickness 
of back-scattering layer from the measurement point to provide sufficient scattering. 
In this study, the XVMC code responded to IC measurements with the differences of 
+0.3, -0.1 and -0.3%, respectively, and the EGSnrc code responded with the differences of +0.8, 
+0.4, and +0.2%, respectively. The results were listed in Table 2. 
Depth (cm) XVMC EGSnrc 
10 0.3% 0.8% 
20 -0.1% 0.4% 
30 -0.3% 0.2% 
 
Table 2.Dose difference of MC calculation from the IC measurement at the isocenter 
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3.1.1.1 Under homogeneous phantom 
Absolute doses to water at the beam axis measured by the IC array and those calculated 
by the MC simulations were inter-compared for various phantom thicknesses and field sizes, as 
shown in Figure 11 (a) and Table 3. The couch attenuation was determined to be 2.3% with IC 
measurement, averaged over field sizes of 5×5 to 15×15 cm2 and phantom thicknesses of 0 to 30 
cm. The variation of the attenuation over the measurement conditions was less than 0.5%. This 
factor was applied to all dose-to-water calculations in this study. Table 3 showed that the 
maximum difference of the EGSnrc code was determined to be +2.8% for the field size of 5×5 
cm2 under phantom thicknesses of 10 and 20 cm and that of the XVMC code was +2.2% for the 
same field size under the 20 cm-thick phantom.  
 
  Homogeneous Phantom Thickness    
Field Size  10 cm  20 cm  30 cm  Average 
(cm²)  EGSnrc XVMC  EGSnrc XVMC  EGSnrc XVMC  EGSnrc XVMC 
5 × 5  2.8% 1.7%  2.8% 2.2%  1.8% 1.3%  2.5% 1.7% 
10 × 10  1.3% 1.0%  2.0% 1.4%  1.7% 0.5%  1.6% 1.0% 
15 × 15  1.1% 0.7%  1.1% 0.4%  1.0% 0.4%  1.1% 0.5% 
Average  1.7% 1.1%  1.9% 1.3%  1.5% 0.7%  1.7% 1.1% 
 
Table 3. Differences between calculated doses by MC codes and measured doses in the IC array 
of irradiations through homogeneous phantoms at the beam axis in the EPID plane.  
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Figure 11. Inter-comparison of absolute dose to water by MC calculations and IC array 
measurements in the EPID plane under homogeneous phantoms. (a) Doses at the beam axis. (b) 
Off-axis dose profiles. Phantom thicknesses of 10, 20, and 30 cm and field sizes of 5×5, 10×10 
and 15×15 cm
2
 were used. Each graph displays results measured by ion chamber array, results 
calculated by the XVMC code (with the phase space source model), and results calculated by the 
EGSnrc/DOSXYZnrc code. 
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At the largest field size of 15×15 cm2, both EGSnrc and XVMC codes provided the 
closest agreements for all phantom thicknesses. For the two codes, as the field size increased 
from 5 x 5 cm2 to 15 x 15 cm2, the calculated outputs relative to the IC outputs changed by 
greater than 1%, decreasing the MC over-response.  
From the above differences in water dose at the isocenter, it was found that in the plane 
of EPID the two codes provided increased differences, as listed in Table 3, by producing greater 
relative responses to the ion chamber responses at the isocenter in Table 2. For example, the 
differences of +2.0% vs. +0.4% for the EGSnrc code and +1.4% vs. -0.1% for the XVMC code 
at the condition of a 20 cm thickness and 10×10 cm2. In spite of the above variations, overall, the 
results of MC calculations showed small errors, less than the 2.8%.  
As stated in the section 2.1.3, the MC accuracy is fundamentally influenced by the 
physics model of each code, which in turn affects the accuracy of the fluence at the level of 
EPID. It can be explained that the differences, found above and throughout this study, between 
the calculations and the measurements have been contributed by the level of such fundamental 
accuracy achievable by the MC codes, affected by the realized commissioning accuracy of them. 
As shown in the commissioning result, the output was decreased as the depth in the phantom 
increased; the same thickness effect was shown at the EPID plane. Therefore, it may be 
considered that higher response at the exit plane was due to the air gap, which yielded inaccurate 
scattering calculation in the air gap between the phantom placed at the isocenter and the EPID 
plane. However, the differences between the simulation results and the measurements agreed 
within less than 3%. 
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Off-axis profiles were inter-compared between calculations and measurements in Figure 
11 (b). The average differences were acquired across the in-field regions (excluding penumbra 
area; 80% of FWHM) with a maximum standard deviation of 0.5% for all profiles throughout 
this study. Among the differences for all conditions, the maximum average differences (the 
maximum value among the average differences of each condition) were found to be 3.3 and 2.3% 
for the EGSnrc and XVMC codes, respectively, under the thickness of 20 cm and field size of 
5×5 cm2 as shown in Table 4. The maximum point differences (the maximum value among point 
maximums of each condition) were found to be 3.9 and 2.8% for the two codes, respectively, 
under the same condition. The maximum point differences were affected by proximity of their 
locations to high-dose-gradient regions (penumbra or heterogeneous interface) and MC noise in 
addition to the above fundamental reasons.  
Calculated dose-to-water profiles by the XVMC code based on the virtual source and the 
phase space models were compared with the measurements from IC array placed at the EPID 
distance in Figure 12. A 20 cm-thickness phantom and the field size of 10×10 cm2 were used. 
The phase space model provided a slightly better agreement in the in-field region and sharpened 
penumbra profiles. Note that the XVMC code with its inherent virtual source model is optimized 
for dose calculation in a water medium, and thus the virtual source model still provided a good 
agreement with measurements in water [103]. 
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Irradiation 
Condition 
  Average Difference   Point Maximum 
Field 
Size 
(cm
2
) 
Phantom 
Thickness 
  XVMC EGSnrc   XVMC EGSnrc 
5x5 10 cm 
 
1.8% 3.0% 
 
2.2% 3.4% 
 
20 cm 
 
2.3% 3.3% 
 
2.8% 3.9% 
 
30 cm 
 
1.4% 2.3% 
 
2.2% 3.0% 
10x10 10 cm 
 
1.3% 2.0% 
 
2.1% 2.9% 
 
20 cm 
 
1.5% 2.2% 
 
2.2% 2.7% 
 
30 cm 
 
1.0% 1.9% 
 
1.9% 2.6% 
15x15 10 cm 
 
0.9% 1.2% 
 
1.9% 2.1% 
 
20 cm 
 
0.9% 1.3% 
 
1.9% 2.1% 
  30 cm   0.7% 1.2%   1.5% 1.9% 
 
Table 4. Summary of differences across in-field regions in the plane of EPID between calculated 
doses by MC codes and measured doses in the IC array of irradiations through homogeneous 
phantoms.  
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Figure 12. Inter-comparison of calculated dose-to-water profiles with phase space and virtual 
source models with reference to measurement by the ion chamber array. The experimental 
condition was under a 20 cm-thickness homogeneous phantom and the field size of 10×10 cm
2
. 
The penumbra slope was slightly steeper when the phase space file was used. 
 
3.1.1.2 Under heterogeneous phantoms 
Absolute dose profiles under the heterogeneous phantoms are shown in Figure 13. The 
profiles are quantitatively evaluated in Table 5 in terms of average differences between the 
calculations and the measurements. The average differences were sampled across the in-field 
region (excluding penumbra and interface between water and lung/bone phantoms; 80% of 
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FWHM). The EGSnrc code yielded its maximum average difference of 2.9% under the bone 
phantom (in the water side) when the field size of 5×5 cm
2
 and the total phantom thickness of 13 
cm were used; the maximum point difference was 3.6% found in the same region under the same 
condition. The XVMC code yielded a maximum average difference of 2.3% and a maximum 
point difference of 2.7% in the same region under the same condition, where it was under the 
bone phantom. 
 
  
Field 
Size 
(cm
2
) 
Phantom 
Thickness 
Maximum Average Difference   Maximum Point Difference 
XVMC EGSnrc   XVMC EGSnrc 
Lung  5x5 15 cm 1.4% (Water) 1.4% (Water) 
 
1.8% (Water) 1.5% - 
  
25 cm 1.7% (Water) 1.4% (Lung) 
 
2.0% (Water) 1.6% (Water) 
 
10x10 15 cm 0.7% (Water) 1.0% (Lung) 
 
2.3% (Water) 1.7% (Water) 
  
25 cm 0.9% (Water) 0.9% (Water) 
 
2.1% (Water) 1.6% - 
 
15x15 15 cm -0.9% (Lung) 0.4% (Water) 
 
1.9% (Water) 0.9% (Water) 
    25 cm -0.7% (Lung) 0.7% (Water)   1.9% (Water) 1.3% (Lung) 
Bone 5x5 13 cm 2.3% (Bone) 2.9% (Water) 
 
2.7% (Bone) 3.6% (Water) 
  
23 cm 1.9% (Bone) 2.6% (Water) 
 
2.4% (Bone) 3.4% (Water) 
 
10x10 13 cm 1.5% (Bone) 1.8% (Water) 
 
2.5% (Bone) 2.8% (Water) 
  
23 cm 1.5% (Bone) 1.9% (Water) 
 
1.9% (Bone) 2.8% (Water) 
 
15x15 13 cm 0.8% (Bone) 0.7% (Water) 
 
1.9% (Bone) 2.0% (Water) 
    23 cm 0.8% (Bone) 0.8% (Water)   2.1% (Water) 1.8% (Water) 
 
Table 5. Summary of differences across in-field regions in the plane of EPID between calculated 
doses by MC codes and measured doses in the IC array of irradiations through heterogeneous 
phantoms. (Parenthesis represents the difference was found in which side of the phantom) 
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Figure 13. Inter-comparison of absolute dose-to-water profiles of MC calculations and IC array 
measurements across the EPID plane under heterogeneous (a) lung and (b) bone phantoms for 
field sizes of 5×5, 10×10 and 15×15 cm
2
. Profiles for two sets of phantom thicknesses were 
provided in each graph. Each graph displays the profile measured by the ion chamber array, the 
profile calculated by the XVMC code and the profile calculated by the EGSnrc code. In each 
graph, the left half was under the water-equivalent phantoms and the right half was under the 
lung or bone sandwiched slabs. 
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Both EGSnrc and XVMC results showed the same field-size dependence as their 
performance in homogeneous phantoms: for all thicknesses, the error was largest for the smallest 
field size and decreased as the field size was increased.  
Also, it was found that the average differences of the XVMC calculations are different 
between the lung and the water sides for all field sizes and thicknesses. This came from the fact 
that the relative outputs of the calculations to the IC outputs were smaller in the lung side than 
those under the water side. This finding is in contrast to the performance of the EGSnrc code that 
shows similar differences between the two sides, and thus the similar relative outputs for all field 
sizes and thicknesses. For example, for the XVMC code,
 
under the 15-cm lung phantom and the 
field size of 10 x 10 cm
2
 the difference on the lung side was -0.5%, compared with +0.7% for the 
difference on the water side; for the EGSnrc code, under the same condition these differences 
were +1.0% and +0.9%, respectively. This finding could be attributed to the limited accuracy 
reported for XVMC calculations in lung materials, compared with its performance in tissue-
equivalent materials [72], affected by the commissioned accuracy of MC codes, discussed above. 
Overall, both XVMC and EGSnrc results showed good agreement with the IC array 
measurements within the maximum error of 3.6%.  
 
3.1.2 Dose to EPID: EPID model validation 
3.1.2.1 Under homogeneous phantoms 
Figure 14 shows ratios of measured pixel values of EPID to calculated doses in the EPID 
models at the central axis. The ratios functioned as scale factors for dose-to-pixel value 
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conversions that are dependent on field sizes and phantom thicknesses in this study. In the figure, 
they were normalized at the condition of the field size of 10×10 cm
2
 and the thickness of 20 cm 
at which two-dimensional dose-to-image calibration was performed. Across all thicknesses and 
field sizes, the ratios varied between 0.97 and 1.04 for the EGS model and between 0.92 and 1.07 
for the XVMC model. With the smaller variation, the EGSnrc model performed more closely to 
the actual EPID, which can be explained by the better modeling achieved by incorporating the 
elemental compositions of the EPID structures. Both EPID models showed the same trend of the 
ratios: the measured pixel values/the calculated dose increased as the field size increased. This is 
similar to the trend of calculated dose/measured dose in water (Table 3 and Figure 11 (a)). 
However, the dependence of the ratios on field-size changes was much greater in the EPID 
models. In spite of the more realistic modeling of EPID as described above, the variance of the 
ratios implies deficiency in the accuracy of modeling, which could be related to the inaccuracy of 
elemental compositions available for EPID structures. The fact that the ratios increased with 
increasing field sizes and decreasing phantom thicknesses can be explained if the effective 
atomic number in the EGSnrc model is lower than the actual number. Low energy photons, 
which greatly interact with high atomic number materials, are more abundant as the field size 
increases and the phantom thickness decreases. A greater effective atomic number in the actual 
EPID caused its relatively higher response to the response of the EGSnrc model as the field-size 
increased and the phantom thickness decreased. The XVMC model, although it employed Zeff, in 
principle could not experience low-energy over-response of high atomic number elements that 
are present in EPID. This explains a greater variation of the ratios. However, increasing Zeff even 
higher than actual physical value would not enough to reduce the magnitude of ratios, since the 
hypersensitivity of the aSi EPID is mainly due to the phosphor layer [41], [42]. To overcome this 
45 
 
problem, energy kernel may be introduced to compensate for the energy dependency of the 
virtual detector model in EGSnrc code. For Zeff corrected model in XVMC code, the dose 
calculation routine in the EPID layer may need to be modified. 
Profiles of calculated dose images and measured images in EPID for various phantom 
thicknesses and field sizes were shown in Figure 15. The average difference of the EGSnrc 
model was 0.6% and the maximum point difference was 2.0% within the in-field regions as 
shown in Table 6 in spite of MC calculation noises for all conditions. The maximum average 
difference and the maximum point differences were found under the 30 cm-thick phantom and 
the field size of 5 x 5 cm
2
. The average differences of the XVMC model were less than 0.4% and 
the point differences were less than 1.2% within the in-field regions for all conditions. They were 
found under the same condition above. The penumbra profiles of the two EPID models matched 
well to the measurements. The small differences came from the calibration based on the above 
ratios. Unlike the response of the MC codes in the plane of EPID, the performance of the EPID 
models were not affected by the dependence of their outputs on the changes of a field size and a 
phantom thickness or the increase of outputs in the EPID plane. 
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Irradiation 
Condition 
  Average Difference   Point Maximum 
Field 
Size 
(cm
2
) 
Phantom 
Thickness 
  XVMC EGSnrc   XVMC EGSnrc 
5x5 10 cm 
 
0.4% 0.5% 
 
1.0% 1.3% 
 
20 cm 
 
0.1% 0.3% 
 
0.8% 0.7% 
 
30 cm 
 
0.4% 0.6% 
 
1.2% 2.0% 
10x10 10 cm 
 
0.2% 0.3% 
 
1.2% 1.4% 
 
20 cm 
 
0.4% 0.1% 
 
1.1% 1.0% 
 
30 cm 
 
0.1% -0.1% 
 
1.1% -1.2% 
15x15 10 cm 
 
-0.3% -0.1% 
 
-1.2% -0.7% 
 
20 cm 
 
0.0% -0.3% 
 
-0.8% -1.0% 
  30 cm   -0.2% -0.5%   1.1% -1.7% 
 
Table 6. Summary of differences across in-field regions in the plane of EPID between calculated 
doses by MC codes and measured doses in the EPID of irradiations through homogeneous 
phantoms. 
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Figure 14. Ratios of measured pixel values of EPID to calculated dose in the (a) EGSnrc and 
XVMC (density scaled only) and (b) EGSnrc and XVMC (Zeff and phase space correction) 
models of EPID as functions of field size and phantom thickness. The ratios were normalized at 
the field size of 10×10 cm
2
 under a 20 cm-thick phantom. (Note that the maximum thickness 
used in density scaled model was 38 cm instead of 30 cm. The density scaled only data in (a) 
was reproduced from the previous study [71]. 
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A noticeable change between the previous density-scaled XVMC model [71] and the 
new Zeff-corrected XVMC model is that the ratios of the new model showed an increasing trend 
as field sizes increase, while the ratios of the previous model showed a minimum at an 
intermediate field size. The trend of the new model became similar to the trend of the EGSnrc 
model by considering Zeff. This is encouraging because the outputs of the XVMC model 
simulated those of the actual EPID and the calibration factors (ratios in Figure 14) show a trend 
approaching linearity. This finding was not affected by the choice of the source models. In 
addition, an improvement in penumbra profile calculations was made as shown in Figure 16 by 
employing the phase space file from the EGSnrc code instead of the virtual source model used in 
the XVMC code. This change can be explained by the fact that the virtual source model is 
optimized for dose calculation in water equivalent or similar materials only [103], and thus is not 
suitable for modeling beam profiles measured in such heterogeneous media of EPID (compare 
Figure 16 with Figure 12).  
All calculations in this study were performed by a computer equipped with dual 6 core 
2.93 GHz Intel Xeon CPUs and 12 GB RAM. The total calculation time for the condition of a 20 
cm-thick homogeneous phantom and the field size of 10×10 cm
2
 was 1.2 hours for the XVMC 
model, while it took 14.9 hours for the EGSnrc model.  
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Figure 15. Inter-comparison of EPID image profiles by calculations in the EGSnrc and XVMC 
models of EPID and measurements in EPID under homogeneous phantoms. The phantom 
thicknesses of 10, 20, and 30 cm were used; the field sizes were 5×5, 10×10 and 15×15 cm
2
. The 
XVMC model was calculated with the Zeff structure model and the phase space source model. 
The EGSnrc model was calculated with the virtual detector model. 
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Figure 16. Inter-comparison of EPID image profiles calculated in the Zeff–corrected XVMC 
model with the phase space and the virtual source models and measured in EPID for the field 
size of 10×10 cm
2
 and a 20 cm-thick homogeneous phantom. The profiles were normalized at 
the beam axis. 
 
 
3.1.2.2 Under heterogeneous phantoms 
Calculated EPID dose images were similarly compared with measured images for the 
heterogeneous phantoms and field sizes described in the method section in Figure 17 and Table 7. 
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The comparison showed average differences less than 0.7% for the EGSnrc model for all 
conditions. The maximum was found under the lung side of the 15 cm-thick phantom with the 
field size of 15×15 cm
2
. The maximum point difference was 1.4% under the same condition as 
shown in Table 7. The maximum average difference for the XVMC model was found to be 1.3% 
for the lung side of the 15 cm-thick phantom with the field size of 5×5 cm
2
. The maximum point 
difference was 1.9% under the same condition. 
 
  
Field 
Size 
(cm
2
) 
Phantom 
Thickness 
Maximum Average Difference   Maximum Point Difference 
XVMC EGSnrc   XVMC EGSnrc 
Lung  5x5 15 cm -1.3% (Lung) 0.3% (Water) 
 
-1.9% (Lung) 0.7% (Lung) 
  
25 cm -0.9% (Lung) 0.1% (Water) 
 
-1.1% (Lung) -1.2% (Water) 
 
10x10 15 cm -1.0% (Lung) -0.2% (Water) 
 
-1.8% (Lung) 1.3% (Lung) 
  
25 cm -0.5% (Lung) 0.3% (Lung) 
 
-1.0% (Lung) 1.1% (Water) 
 
15x15 15 cm -1.1% (Lung) 0.7% (Lung) 
 
-1.7% (Lung) 1.4% (Lung) 
    25 cm -0.2% (Lung) 0.3% (Lung)   -0.6% (Lung) -1.2% (Water) 
Bone 5x5 13 cm 0.3% (Water) 0.3% (Water) 
 
0.9% (Bone) -1.1% (Water) 
  
23 cm 0.2% (Bone) 0.3% (Bone) 
 
0.8% (Bone) 0.9% (Bone) 
 
10x10 13 cm 0.4% (Bone) 0.2% (Bone) 
 
1.6% (Bone) -0.8% (Water) 
  
23 cm 0.4% (Water) 0.6% (Bone) 
 
1.7% (Bone) 1.3% (Bone) 
 
15x15 13 cm -0.3% (Water) 0.2% (Bone) 
 
-0.9% (Water) 0.9% (Bone) 
    23 cm 0.0% - 0.2% (Water)   0.7% (Bone) 1.0% (Bone) 
 
Table 7. Summary of differences across in-field regions in the plane of EPID between calculated 
doses by MC codes and measured doses in the EPID of irradiations through heterogeneous 
phantoms. (Parenthesis represents the difference was found in which side of the phantom) 
 
52 
 
 
Figure 17. EPID image profile inter-comparison among the calculations of the EGSnrc and 
XVMC models and measurements under (a) heterogeneous lung and (b) bone phantoms for field 
sizes of 5×5, 10×10 and 15×15 cm
2
. Profiles for two sets of phantom thicknesses were provided 
in each graph. In each graph, the left half was under the water-equivalent phantoms and the right 
half was under the lung or bone sandwiched slabs. Each graph displays the profile measured by 
EPID, the profile calculated by the XVMC EPID model (with the Zeff structure model and phase 
space source model), and the profile calculated by the EGSnrc EPID model (with the virtual 
detector model). 
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Similar to the performance in the water phantom, the XVMC model produced different 
amounts of differences between the lung and the water sides for each field size and thickness, 
while the EGSnrc model produced similar amounts of differences as listed in Table 7. The 
differences of the XVMC model under the lung phantom were greater for the thinner phantom 
(15 cm-thick) than for the thicker phantom (25 cm-thick): of note, the differences were -1.3% vs. 
-0.9%, -1.0% vs. -0.5%, and -1.1% vs. -0.2% for the field sizes of 5x5, 10x10, and 15x15 cm
2
, 
respectively. When it comes to the bone phantoms, there is no marked difference between the 
performances of the two models for each field size and thickness. These findings may be 
explained in the followings. The EPID images (i.e. pixel values) were obtained from calculated 
doses in the models through calibration that is dependent on field sizes and thicknesses of the 
water phantoms (not the lung/bone side). Therefore, greater differences were expected on the 
lung/bone side. This, however, did not have much impact on the results in Table 7, given the 
small differences between the effective thicknesses of the lung/bone side and those of the water 
side tried in this study. In support of this argument, the trend of data (differences under the 
lung/bone phantoms compared with those under the water phantoms for the two codes) in Table 
5 appeared to be extended to that in Table 7 with one exception, the XVMC model under the 25 
cm lung phantom and the field size of 15 x 15 cm
2
. Thus, the trend of the above data was 
contributed mainly by the performance of the two codes, affected by the fundamental MC 
accuracy discussed above and secondarily by the calibration adopted in this study. Note that this 
argument is applicable to the level of heterogeneity of phantoms tried in this study; in reality, the 
effective thicknesses in patients could be more variable.     
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As shown in Table 7, the maximum average differences and the maximum point 
differences were reduced from the calculations in water to the calculations in the EPID models 
for all conditions of field sizes and thicknesses (compare 3.3% for the EGSnrc code with 0.7% 
for the EGSnrc model; compare 2.3% for the XVMC code with 1.3% for the XVMC model). 
Also, although the EGSnrc code was associated with a greater difference in water than the 
difference of the XVMC code for all conditions of field sizes and thicknesses, it was with a 
smaller difference in the model. This change was achieved by the calibration adopted in this 
study and the fact that the EGSnrc model is associated with a smaller variation of the ratios for 
the calibration than that of the XVMC model.  
 
 
3.2 Four-dimensional dose reconstruction with the phase sorting method 
3.2.1 Phase sorting results 
The phases at acquired EPID images were determined by 2D gamma comparison 
method. The tumor locations and corresponding EPID images were shown in Figure 18. In the 
diagram, phase 0 was max-exhale and phase 5 was max-inhale. Since the breathing motion in 
this experiment was sinusoidal, the phase at the same amplitude (displacement from the one end 
of the motion) cannot be distinguished whether it was during inhale or exhale motion. For 
example, the location of phase 1 was the same to that of phase 9, and phase 2 was the same to 
phase 8, etc. As a result, some reference phases were not used as a result of the phase sorting. 
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Figure 18. Look-up EPID images for sinusoidal breathing motion. (a) Simplified patient’s 
breathing phase and corresponding EPID images by phase was shown. EPID images at phase 2 
and 8 are the same. (b) Simulation result of look-up EPID images by reference phase from 4D 
CTs. (Note; the images used in (b) are predicted EPID images from a 4D CT set. The artifacts in 
the images (phase 3, 8, 9) were resulted from 4D CT motion artifacts.) 
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 The 2D gamma values were calculated between a measured EPID image and a look-up 
EPID image at a reference frame, as shown in Figure 19. Note that the gamma criteria or 
absolute pass rate are meaningless in this comparison, since the purpose of this comparison is to 
find out the closest look-up EPID image from the measured image. The sorted phases were 
shown in Figure 20. Since the amplitude of the breathing motion is symmetry for inhalation and 
exhalation, only phase 0~5 were used for the phase sorting. Some images were sorted in adjacent 
phase of the predictions which were determined from the phantom motion; this could be due to a 
slight misalign of the experiment or motion blurring [108] of the 4D CT images. For the EPID 
images when the tumor was shadowed by MLCs, the phase was assigned manually based on the 
phase sorted result when the tumor was visible. For frame number 50 to 70 in sliding window, 
the tumor was half-shadowed by the MLCs and the phase sorting result was coincident to the 
manual sorting result. After then, the tumor was completely covered by the MLCs and the 
manual sorting method was used. 
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Figure 19. Examples of 2D gamma comparison result for the phase sorting. The results from 
IMRT field were shown. The pictures show 2D gamma map for a measured phase when a 
reference phase of look-up EPID images was (a) matched and (b) mismatched. The sum of 
gamma indices was lower for (a) and the phase was determined accordingly. The gamma values 
were calculated only for in-field (threshold 15% of maximum pixel value) 
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Figure 20. Sorted phase numbers of acquired EPID images and the predicted phase by phantom 
motion for (a) open field, (b) sliding window and (c) IMRT field. Phase 0 and 5 were longer than 
others since they were max-exhale and max-inhale, respectively. Frames where the tumor was 
hidden by MLCs were represented (shadow box) in the graph. 
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3.2.2 Reconstructed dose evaluations 
The phantom doses were reconstructed from the sorted EPID images. The reconstructed 
doses were compared with forward calculations on MIP, AIP and 4D CT by DVHs and 2D dose 
at the isoplane. The result for the open field was shown in Figure 21. In the figure, “4D plan” 
(forward calculation) and “Reconstructed” were compared. Greater dose differences and gamma 
values are found near the edge of the tumor than the values in other areas on the coronal 
isocentric plane, as shown in Figure 21 (c) and (d), respectively. This was affected by the phase 
misalignment of the cine images discussed in section 3.2.1. Gamma pass rate was 92.7% for the 
3%/3mm criteria, where the failure points were mainly at the tumor boundary. DVHs on AIP and 
MIP were higher than 4D doses and they showed very similar curve. Also, 4D forward and 
reconstructed doses were in good agreement. The evaluation of DVHs shows that the 4D 
reconstruction was performed accurately enough to cause close agreement between the 
“Reconstructed” with the “4D planed.” The 3D dose calculations (“Planned” - both MIP and AIP) 
showed a greater DVH trends in PTV than the other two. This implies that the 3D dose 
calculation performed on an image of a moving target with margins of the internal motion and 
the setup uncertainty conservatively estimated dose, compared with the realistic “4D plan.” The 
fact that the DVHs of the “Planned” were greater was likely resulted from the relative low dose 
coverage of the 4D cases when the locations of the tumor were closer to the boundaries of the 
irradiated field. The 3D dose calculations also showed different DVH trends in lung, 
overestimating volume coverage in high dose regions. This can be in part explained by the 
presence of greater lung volumes in 4D dose calculation than those in 3D dose calculation which 
employed MIP in this study. 
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Figure 21. Dose distributions on the coronal isocentric plane for the open beam. (a) Planned dose 
on 4D CT image, (b) reconstructed dose by the phase determination method, (c) difference 
between planned and reconstructed dose, and (d) 2D gamma map. 2D gamma pass rate was 92.7% 
for 3%/3mm criteria. (e) DVHs in PTV of forwardly calculated doses on MIP and 4D CTs, and 
reconstructed 4D dose. (f) DVHs in lung. (The resolution of (a)-(d) was 2.5×1.0 mm
2
) 
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The result for the sliding window was shown in Figure 22. Similarly, “4D plan” and 
“Reconstructed” were compared. Although not as obvious as Figure 6, greater dose differences 
and gamma values are found near the edge of the tumor than the values in other areas on the 
coronal isocentric plane, as shown in Figure 22 (c) and (d), respectively. The higher gamma 
values were found near the edges of MLCs that moved which was synchronized with the 
phantom motion during irradiation as shown in Figure 22 (d). DVHs of static volume were lower 
than 4D for the same region. The gamma pass rate was 100.0% for 3%/3mm criteria, where it 
was decreased 91.6% when 1%/1mm criteria were applied. It was greater than the result of the 
open beam, due to smoother variation of the dose, near the target edges, that tends to lower 
gamma value. In addition to the high gamma pass rate, the evaluation of DVHs shows that the 
4D reconstruction was performed accurately enough to cause close agreement between the 
“Reconstructed” with the “4D plan.” The “Planned” on MIP and AIP showed smaller DVH 
trends in PTV as well as lung than the 4D dose. This could be affected by the greater portions of 
the PTV and the lung blocked by the moving MLCs during irradiation, while the planning CT 
image was stationary, than those of the 4D cases. The DVHs for MIP and AIP showed a straight 
line since the MLCs were moving with a constant speed, where 4D doses were curved due to 
partial exposure on the tumor during the tumor-MLCs interplay. Also, the DVHs for MIP and 
AIP showed a monotonic curve in lung. The trend of the “4D plan” and “Reconstructed” showed 
differences from “Planned”, due to modeling of partial exposures on the tumor that occurred 
during irradiation.  
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Figure 22. Dose distributions on the isocenter plane for the dynamic beam. (a) Planned dose on 
4D CT image, (b) reconstructed dose by the phase determination method, (c) difference between 
planned and reconstructed dose. (d) 2D gamma map. 2D gamma pass rate was 100% for 
3%/3mm criteria. (e) DVHs in PTV for forwardly calculated doses on MIP and 4D CTs, and 
reconstructed 4D dose. (f) DVHs in lung. (The resolution of (a)-(d) was 2.5×1.0 mm
2
) 
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Figure 23 shows the result of the IMRT field. The MLCs were closed at the beginning, 
then opened widely and finally closed. The MLCs moving direction was same to the tumor 
motion. DVHs of 4D doses (“4D plan” and “Reconstructed”) had better coverage than DVHs of 
static volume due to the synchronization between MLCs and phantom movement. Gamma pass 
rate was 98.1% for 3%/3mm criteria. It was lower than sliding window but higher than open field, 
since the phase mismatching appeared in the open field case was not observed in the IMRT field, 
as shown in Figure 20. The accurate performance of the 4D reconstruction was repeated, 
showing close agreement between the “Reconstructed” with the “4D plan.” Similarly to Figure 
22, “Planned (MIP)” and “Planned (AIP)” showed smaller DVH trends in PTV as well as lung 
than the other two. 
 While the agreement between the “Reconstructed” and the “4D plan” was encouraging, 
the small extent of differences between them, as shown in Figures 21(c), 22(c) and 23(c), came 
from multiple factors. First, as explained above, the phase mismatching played a major role. 
Second, the inverse 4D dose reconstruction algorithm used in this study does not employ 
segment-specific dose response calculations, but virtual beam let calculations from open fields 
that are slightly greater than the largest IMRT fields. The forward 4D dose calculation on the 
other hand employed segment-specific dose calculations. Third, since the displacement of tumor 
locations between phases (1.9 mm) near maximum inhale/exhale in this experiment is smaller 
than the CT slice thickness (2.5 mm), it is vulnerable to be sorted in adjacent phase. In spite of 
the above constraints, the generous tolerance of the gamma test (3% and 3 mm) and the 
cumulative nature of DVH did not show serious disagreement. 
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Figure 23. Dose distributions on the isocenter plane for the IMRT beam. (a) Planned dose on 4D 
CT image, (b) reconstructed dose by the phase determination method, (c) difference between 
planned and reconstructed dose. (d) 2D gamma map. 2D gamma pass rate was 98.1% for 
3%/3mm criteria. (e) DVHs in PTV for forwardly calculated doses on MIP and 4D CTs, and 
reconstructed 4D dose. (f) DVHs in lung. (The resolution of (a)-(d) was 2.5×1.0 mm
2
) 
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3.2.3 Phase sorting method evaluation: XCAT phantom test 
To evaluate the presented phase sorting method using 2D gamma values in a realistic 
case, the generated MV DRR from the XCAT software package was treated as a measured EPID 
image in this experiment.  Since the DRR image response is different from that of EPID image, 
there was mismatch in intensity of pixels after calibration due to difference in energy response of 
the EPID. However, since the phase sorting method utilizes the summed gamma values, the 
discrepancy of the pixel values would not affect the sorted phase. Since the dose reconstruction 
was not performed in this test, the pixel values were normalized to unity for ease of gamma 
comparison. The DRR and look-up EPID images were shown in Figure 24. 
Figure 25 shows summed gamma values by comparing the DRR with each phase of 
look-up EPID image. The result shows that the minimum gamma value was found at the phase 3, 
which is matching to the phase of DRR. Figure 26 shows actual 2D gamma distribution where 
the DRR was compared with look-up EPID image of phase 3 and 5. In Figure 26 (a), there was 
high gamma value region at the dose gradient region; it was considered that the pixel response in 
DRR was different from that of EPID image. When gamma values were calculated with the look-
up image at phase 5, similar discrepancy was observed, where additional mismatch appeared 
around the tumor. The phase of “measured” EPID image was successfully determined as phase 3. 
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Figure 24. MV images used for the phase sorting evaluation. The images were calculated from 
digital XCAT phantom. (a) Generated DRR image and (b) look-up EPID image for phase 3. The 
difference between (a) and (b) is shown in (c). The pixel resolution was 3.1 x 1.6 mm
2
. 
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Figure 25. Summed gamma values by comparing the DRR (regarded as a measured EPID image) 
with look-up EPID images simulated from digital XCAT phantom. 
 
Figure 26. 2D gamma evaluation map for the phase sorting. The “measured” EPID image in 
phase 3 was compared with look-up EPID image at (a) phase 3 and (b) phase 5, respectively 
4. CONCLUSION 
4.1 EPID modeling in XVMC codes 
A new model of EPID in the XVMC code was developed by incorporating effective 
atomic numbers of elemental components of EPID structures and adopting the phase space 
source from the EGSnrc code into the density-scaled model previously developed [71]. A virtual 
detector model [58] of EPID was also developed in the EGSnrc code. The EGSnrc and XVMC 
codes in water phantom at the plane of EPID were found to perform within the accuracy of 3.9 
and 2.8%, respectively. For the EPID image comparison, using the calibration factors that are 
dependent on field sizes and thicknesses for the conversion of calculated images to measured 
images, the EGSnrc and XVMC models were found to perform within the accuracies of 1.4 and 
1.9%, respectively. Since the raw pixel value on the measured EPID image is not an absolute 
value that can be physically interpreted but requires additional calibration depends on 
measurement condition, the values were normalized at 10×10 cm
2
 field size under a 20 cm 
homogeneous phantom in this study. As a result, the differences in the EPID simulations were 
lower than that of water dose comparison. 
The Zeff correction incorporated into the XVMC model improved physical performance 
of the calibration factors, compared with that of the density-only-scaled model. The use of phase 
space files from the EGSnrc/BEAMnrc code significantly improved agreement of calculated 
profiles with measured profiles in penumbra regions. Demonstrating superior accuracy, the two 
MC models may be used for accurate in vivo dosimetry of radiation therapy. However, 
significant amounts of calculation time can be saved by using the XVMC model (12.4 times 
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faster). Therefore, the EPID image prediction model in XVMC code was used in the 4D dose 
reconstruction with phase sorting method and further evaluated. 
 
4.2 Four-dimensional dose reconstruction with the phase sorting method 
A 4D dose reconstruction method with phase-sorted cine EPID images for a breathing 
phantom was developed and demonstrated. The acquired cine EPID images during a treatment 
were determined by comparing with predicted look-up EPID images and assigned to the 
reference phases by 2D gamma method. For the phases that the tumor was shadowed by the 
MLCs, the phase was determined manually by breathing phase extrapolation from the known 
breathing motion. The dose was reconstructed based on the measured EPID images by non-
iterative inverse method and compared with forward calculations on 4D CT, MIP and AIP. The 
reconstructed doses were evaluated by 2D gamma and DVH analysis. The reconstructed doses 
showed good agreements with the forward 4D dose calculations, where showed difference from 
the static 3D dose calculation on MIP or AIP. The difference in DVH was expected since the 
tumor volume to PTV ratio was not the same in 3D and 4D planning. 
The phase determination was performed by 2D gamma method in this study and the 
results were good for the cases studied. Other methods may be used for the phase sorting, such as 
center of mass method (comparing the location of the center of the tumor on the EPID image) or 
2D image deformation technique. However, the differences among possible candidates were not 
evaluated in this study; another phase sorting method could be better for complex anatomy or 
extreme case. The effect from using another phase sorting method may be evaluated in the future. 
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The suggested 2D gamma method was also evaluated with an anthropomorphic 
deformable digital XCAT phantom. Since an EPID image cannot be obtained from digital 
phantom, an MV DRR image was generated for an arbitrary phase and regarded as a measured 
EPID image in this study. The summed gamma value was lowest at the phantom phase where the 
DRR was generated. Therefore, the 2D gamma method for the phase sorting yielded an accurate 
result for the deformable anthropomorphic phantom simulation. 
The accuracy of the reconstructed dose is determined by the accuracy of the CT image 
and the predicted EPID image. In this experiment, the same CT images were used for the 
planning (forward dose calculation) and the in vivo dosimetry (dose reconstruction). Therefore, 
in this study, the agreement between forward calculation and reconstruction is determined by the 
accuracy of the EPID image prediction as well as the accuracy of phase sorting method. It can be 
concluded, therefore, the good agreement of 2D gamma and DVH comparison between 4D 
forward calculation and reconstruction implies that the EPID simulation model was able to 
predict accurate EPID images in this study. 
 
  
5. FUTURE WORKS 
5.1 Future work : 4D CT extension method 
The fast and accurate EPID image prediction model and the 4D dose reconstruction 
method for in vivo dosimetry were developed. As described above, however, the accuracy is 
limited by the accuracy of the CT image and the predicted EPID image. The latter was improved 
by the new EPID model suggested in this study. However, tumor position or patient geometry 
during treatment is still unknown and unpredictable, especially when the patients’ breathing is 
not reproducible between CT acquisition and treatment. Moreover, if the patient breathing 
motion is bigger than expected, the current phase sorting method would not provide an accurate 
reconstructed dose to the patient, since the 4D CT image corresponding to the abnormal 
breathing phase does not exist. When the breathing motion extent exceeded from that presented 
by plan CTs, the problem will be solved if the corresponding patient CT image of the phase is 
presented. Since the breathing phase of this unexpected motion was not obtained from the 4D CT, 
a new CT image should be generated by reconstruction from the pre-acquired CT images. 
To represent the patient at the time of treatment, a CT reconstruction method was tested 
when the respiratory motion of a patient deviated from a motion range that is representative of 
the initial CT [109]. The method utilizes a motion vector acquired from a plan CT and motion 
extent visible in cine EPID images. A feasibility study was performed for the 4D CT extension 
as following. 
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Figure 27. Schematic diagram of deform vector correlation with tumor location on portal images. 
The acquired EPID image is deviated (red circle) where the motion was greater than expected 
amplitude (blue circle) within fixed jaw opening. The motion vectors between phases were 
weighted by the displacement of tumor location on 2D portal images. 
 
To generate a new 4D CT image of the treatment day from the old 4D CT and the portal 
images of the day when the motion extent exceeded from that represented by plan CTs, a motion 
vector of a moving tumor in a patient may be extended to reconstruct the tumor position when 
the motion extent exceeded the plan CTs. To test this, a phantom that consists of a polystyrene 
cylinder (tumor) embedded in cork (lung) was placed on a moving platform with 4 sec/cycle and 
amplitudes of 1 cm and 2 cm, and was 4D-scanned. Then, a 6MV photon beam was irradiated on 
the moving phantoms and cine EPID images were obtained. On cine EPID images of the 1 cm 
73 
 
case, the tumor was outlined and marked for the displacement vector calculation (see blue 
tumors in Figure 27). The displacement vector was calculated based on the correlation of CT and 
EPID images of each phase. When the motion extent exceeded the initial extent (1 cm), the 
displacement on EPID was obtained through tumor outlining and calculation of center-of-mass 
travel (Figure 28), and programmed into the calculated displacement vector. A new CT image 
was thus reconstructed, and compared with the pre-acquired actual CT image (Figure 29). They 
showed a slight mismatch in the transition direction limited by voxel size (slice thickness) in CT 
image. Due to the rigid nature of the studied phantom, the modeling the displacement of the 
center of object was sufficient. When deformable tumors are to be modeled, more complex 
scheme is necessary, which utilize cine EPID and 4D CT images. 
 
 
 
 
Figure 28. Edge detection method was shown. (a) In EPID image, a tumor to be outlined was 
shown. (b) To find out the center of mass, the edge was detected on in-field region of EPID 
image and corresponding voxel transition vector was determined within 4D CTs. 
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Figure 29. Cross-sectional view at the isocenter plane. (a) Reference CT image of 2cm amplitude 
motion with 50% phase (upper), and reconstructed CT image for the same condition by the 
vector extension method (lower). The reference CT image was obtained from 4D CTs with the 
given condition, for the comparison purpose. (b) Density difference map between reference and 
reconstructed CTs was shown around the tumor. Slight mismatch in x-direction is mainly due to 
the limitation of the resolution in CT slice (2.5 mm) 
 
As the CT reconstruction method was successful for the rigid phantom, the method was 
further evaluated using an anthropomorphic XCAT phantom. Phantom geometries according to 
breathing motion were digitally generated; the generated phantoms were regarded as CT images 
in this evaluation. The diaphragm motion was 2 cm amplitude with 4 sec period. A spherical 
shaped tumor was placed in the lower lobe of the lung with 2 cm diameter, where the location 
was changed by the organ deformation according to the breathing motion, as shown in Figure 30. 
The breathing motion was separated in 10 phases, where phase 1 was maximum exhale and 
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phase 6 was maximum inhale. For the test, it was assumed that CT images for phase 1~5 only 
were known, where phase 6 was regarded as “unknown” and used for evaluation purpose only. 
 
 
Figure 30. CT images and corresponding MV images for the evaluation of CT extension. 
(Blue Arrows); CT images for phase 1~5 and corresponding MV images were generated using 
XCAT phantom. (Orange Arrow); The aim of this method is to reconstruct CT image of unknown 
phase using acquired portal image, where the tumor location is exceeded from the expectation. 
 
Since the linear transition model suggested in the rigid phantom case cannot be used in 
the deformable anthropomorphic phantom, the CT image of “unknown” phase was reconstructed 
by following steps. (1) Deformation vectors between phases were obtained. (2) Also, tumor 
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locations were found from the simulated MV images. (3) Finally, the deformation vectors were 
linearly weighted by the displacement of the tumor location (i.e., center of mass) on EPID 
images and a new CT image was reconstructed. 
Figure 31 shows cross-sectional images of the (a)“reconstructed” and (b)”ground truth” 
CTs. The reconstructed image was blurred, compared with the “ground truth” CT image. They 
were inter-compared by (c)cross-sectional profiles and (d)differences in HU values. The 
reconstructed profile showed blurring at the edge of the tumor and other organs. The 
reconstructed tumor location was accurate in displacement less than 3 mm, where it was less than 
1.6 mm for the most points. The difference in HU (Figure 31-d) was mainly due to image 
blurring of the reconstructed CT. 
As a result, the suggested method was able to reconstruct the CT image of “unknown” 
phase based on an acquired portal image. Clinical acceptability of the suggested method will 
further verified by DVH study. 
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Figure 31. 4D CT extension result for the anthropomorphic digital phantom. CT images for (a) 
reconstructed and (b) ground truth were shown. The resolution was 1.6x3.1 mm
2
. (c) Profiles 
near the tumor (on the red dotted line) were shown in (c). The x-axis resolution was 1.6 mm and 
the displacement of the tumor location was less than 1.6 mm. Difference between (a) and (b) in 
HU was shown in (d). 
 
 
5.2 Future work : alternative method for 4D CT reconstruction 
When the tumor position was shifted in lateral (parallel to the EPID plane) direction, it 
will be shown on the EPID image and therefore can be detected in the phase sorting step. 
However, for z-direction (perpendicular to the EPID plane) shift, it cannot be seen on the EPID 
image unless gantry angle was changed. If the tumor location shift (mostly baseline shift in this 
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case) appears in certain gantry angle, it may imply that the position of the tumor was changed. In 
this case, suggested 4D CT reconstruction method cannot be used. 
The method using EPID images to reconstruct patient anatomy has been studied [79], 
[80]. However, the direct MV-CT reconstruction method is limited when there is not enough 
angular information provided. Also, the reconstructed density is not as accurate as kV-CT. 
An alternative method to obtain an accurate CT image could be using a partial 
reconstruction, based on kV-CT by comparing measured EPID images with predictions. From 
the dose reconstruction equation, 
𝐸 = 𝑅𝐸  𝐼   →   𝑅𝐸 =  ∫ 𝐾𝐸  𝑒
−𝜇𝑥 𝑑𝑉     (6) 
𝐸𝑐 = 𝑅𝐸
𝑐  𝐼𝑐    →   𝑅𝐸
𝑐 =  ∫ 𝐾𝐸
𝑐 𝑒−𝜇𝑐𝑥 𝑑𝑉     (7) 
then, combining Eq. (6) and (7), it can be found that 
𝐸𝑐
𝐸
 =  
𝑅𝐸
𝑐 𝐼𝑐
𝑅𝐸𝐼
 =  
∫ 𝐾𝐸
𝑐  𝐼 𝑒−𝜇𝑐𝑥 𝑑𝑉
∫ 𝐾𝐸 𝐼 𝑒−𝜇𝑥 𝑑𝑉
≅  𝑒−(𝜇𝑐−𝜇)𝑥 =  ∑ 𝑒𝑥𝑝(−(𝜇𝑐,𝑛 − 𝜇𝑛)𝑥)𝑛  (8) 
assuming the beam hardening and scattering did not change at the EPID. 
From Eq. (8), the change in attenuation coefficients in a voxel can be found from the 
change in EPID image responses. The change in attenuation coefficients is then converted in 
density change in each voxel of original CT images. Finally, the CT image can be reconstructed 
using pre-obtained kV-CT image by change density values of each voxel. This method may be 
used in multiple-gantry IMRT or VMAT to reconstruct CT image.  
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